In the last trading session, 1.04 million Atyr Pharma Inc (NASDAQ:ATYR) shares changed hands as the company’s beta touched 1.06. With the company’s per share price at $3.49 changed hands at $0.13 or 3.87% during last session, the market valuation stood at $292.96M. ATYR’s last price was a discount, traded about -5.44% off its 52-week high of $3.68. The share price had its 52-week low at $1.08, which suggests the last value was 69.05% up since then. When we look at Atyr Pharma Inc’s average trading volume, we note the 10-day average is 0.72 million shares, with the 3-month average coming to 761.15K.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR was in green as seen at the end of in last trading. With action 10.79%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 147.52%, with the 5-day performance at 10.79% in the green. However, in the 30-day time frame, Atyr Pharma Inc (NASDAQ:ATYR) is 55.80% up. Looking at the short shares, we see there were 1.07 million shares sold at short interest cover period of 1.15 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Atyr Pharma Inc (ATYR) estimates and forecasts
Data shows that the Atyr Pharma Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 91.76% over the past 6 months, a 5.32% in annual growth rate that is considerably lower than the industry average of 17.10%. Year-over-year growth is forecast to reach -29.20% down from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 20k.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 43.36%. The 2024 estimates are for Atyr Pharma Inc earnings to increase by 2.28%, but the outlook for the next 5-year period is at 13.00% per year.
ATYR Dividends
Atyr Pharma Inc is expected to release its next quarterly earnings report in December.
